Biogen Names Michel Vounatsos Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St rises on cooler inflation data, big bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Biogen (BIIB) New CEO Doesn't Change Outlook at Baird
December 20, 2016 12:21 PM ESTBaird analsyt Brian Skorney has no change in his outlook to his Biogen (NASDAQ: BIIB) outlook after the company announced a new CEO. The analsyt also notes his strong commercial background.
Skorney commented, "After a months-long CEO search, Biogen announced appointment of Michel... More
Mizuho Analyst Trys to Explain Why Biogen (BIIB) is Up Despite New CEO News
December 20, 2016 10:59 AM ESTMizuho analyst Salim Syed weighed in on Biogen (NASDAQ: BIIB) with shares trading up on the new CEO announcement; contrary to the view of many on the Street that shares would trade down on the notion M&A would be taken... More
New Biogen (BIIB) CEO Doesn't Take M&A Off the Table - BMO
December 19, 2016 5:42 PM ESTBMO Capital analyst M. Ian Somaiya weighed in on Biogen (NASDAQ: BIIB) after the company named Michel Vounatsos CEO. The analyst said the appointment doesn't take M&A off the table.
Somaiya commented, "We believe Michel Vounatsos brings significant commercial... More
